| Name | 3-(hydroxyamino)-5-nitro-6,7,8,9-tetrahydrobenzo[g]indol-2-one |
|---|---|
| Synonyms |
1H-Benz[g]indole-2,3-dione,6,7,8,9-tetrahydro-5-nitro-,3-oxime
NS 102 6,7,8,9-Tetrahydro-5-nitro-1H-benz[g]indole-2,3-dione 3-oxime |
| Description | NS-102 is a selective kainate (GluK2) receptors antagonist. NS-102 is a potent GluR6/7 receptor antagonist[1][2][3]. |
|---|---|
| Related Catalog | |
| In Vitro | Combination of NS-102 (10 μM) and GYKI 52466 (30 μM) preventes full loss of compound action potentials (CAPs) during oxygen and glucose deprivation (OGD) and increased CAP area recovery[1]. |
| In Vivo | NS-102 (20, 40 or 80 μmol/litre ; in the hippocampal CA3 region) significantly reduces Sevoflurane-induced hyperactivities[1]. |
| References |
| Density | 1.74g/cm3 |
|---|---|
| Boiling Point | 405.8ºC at 760mmHg |
| Molecular Formula | C12H11N3O4 |
| Molecular Weight | 261.23300 |
| Flash Point | 199.2ºC |
| Exact Mass | 261.07500 |
| PSA | 107.51000 |
| LogP | 2.13230 |
| Vapour Pressure | 2.81E-08mmHg at 25°C |
| Index of Refraction | 1.794 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |